Columbia scientists have created new decoy drugs that can intercept the deceptive growth signals that cancer cells send out.
A study of the genomes of patients with a particularly aggressive form of non-Hodgkin’s lymphoma shows that many cases are driven by alterations in the JAK/STAT3 cell signaling pathway.
Nearly 50 years after the “war on cancer” was declared in the United States, precision medicine is changing the face of cancer research.
Advances in how the immune system can be harnessed to fight cancer offer new hope to patients with lung cancer.
Household net worth is a major and overlooked factor in adherence to hormonal therapy among breast cancer patients and partially explains racial disparities in quality of care.